RA Capital Management’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$54.7M Hold
18,750,000
– – 0.55% 33
2026
Q2
$65.4M Buy
+18,750,000
New +$60.4M 0.57% 35

Other funds holding SANA

RA Capital Management's SANA Position: Q3 2026 in Review

RA Capital Management held its Sana Biotechnology (SANA) position steady in Q3 2026 at 18,750,000 shares worth $54.7M. The position accounts for 0.55% of the portfolio, ranked #33.

RA Capital Management first reported a position in SANA in Q2 2026 and has held it in 2 quarters since. The position peaked at $65.4M in Q2 2026. 203 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • RA Capital Management held 18,750,000 shares of Sana Biotechnology worth $54.7M as of Q3 2026.
  • RA Capital Management left its Sana Biotechnology share count unchanged in Q3 2026.
  • Sana Biotechnology made up 0.55% of RA Capital Management's portfolio in Q3 2026, its #33 holding.
  • RA Capital Management first reported a position in Sana Biotechnology in Q2 2026 and has held it in 2 quarters since.
  • RA Capital Management's Sana Biotechnology position peaked at $65.4M in Q2 2026.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.